AFOS ARS Focused Opportunity Strategy ETF

Expense Ratio
0.45%
Dividend
0.23%
Previous close
$45.14
Est. 12 months change
+20.67%
Projected Price
$54.47

Profitability Metrics

Return on Equity (ROE)
55.41%
Return on Assets (ROA)
13.01%
Return on Invested Capital (ROIC)
30.44%
Weighted Average Cost of Capital (WACC)
11.13%
ROIC - WACC
19.31%
Updated : 2026-06-26 20:22 ET

Valuation Metrics

P/E Ratio
29.50
Forward P/E
20.33
PEG Ratio
1.47
Debt Current Ratio
2.12

Growth & Cash Flow

Gross Margin
48.81%
Operating Margin
27.41%
FCF Margin
20.62%
TTM Revenue Growth
61.21%
Projected 12M EPS Growth
45.06%

Price Change

Price % from 50 SMA
4.06%
Price % from 200 SMA
22.36%
6 Months
29.18%
1 Year
78.24%
The above metrics represent weighted averages, calculated using each stock's individual value weighted by its proportion of ETF holdings.

Top 10 Holdings

Stock TickerWeight
MU8.42%
LRCX6.90%
WDC6.49%
GOOGL4.90%
NVDA4.35%
GEV4.14%
MPC3.95%
FCX3.91%
NEM3.91%
PWR3.45%

ETF Analysis

Fund Overview

ARS Focused Opportunity Strategy ETF (AFOS) currently reports 31 stock positions (subject to change), placing it in the selectively diversified range by holdings breadth. The top line-up is MU (8.42%), LRCX (6.90%), WDC (6.49%), with MU as the largest single weight at 8.42%. Together, the top three holdings account for 21.81%, which points to a relatively flat weight distribution where no single cluster of names dominates outcomes. The weight distribution suggests a portfolio designed to capture thematic upside while avoiding excessive dependence on any single name outside the largest positions.

Profitability & Capital Efficiency

Assessing the quality of returns on invested capital, ROIC is 30.44%, WACC is 11.13%, and the economic spread is 19.31%. On balance, the portfolio's businesses are clearing their capital cost hurdle with room to spare. Supporting metrics show ROE at 55.41% and ROA at 13.01%, a combination that helps frame whether profitability strength is broad enough to hold through different market conditions. Taken together, the return profile suggests a portfolio with credible compounding capacity if current operating execution persists.

Valuation

The current pricing of the underlying holdings reads trailing P/E of 29.50, forward P/E of 20.33, PEG of 1.47. The trailing-to-forward compression is moderate — supportive of valuation, but not a dramatic signal of earnings acceleration. The PEG ratio is low enough to suggest the valuation is supported by earnings growth expectations rather than multiple expansion alone. The current ratio of 2.12 is in an acceptable range, reflecting reasonable short-term financial health. In aggregate, the valuation reads as fair to moderately stretched — leaving the investment case dependent on earnings execution rather than multiple expansion.

Margins & Cash Generation

Looking at margins from gross to free cash flow, gross margin sits at 48.81%, operating margin at 27.41%, and free cash flow margin at 20.62%. Gross margins are constructive — not exceptional, but indicative of businesses with reasonable unit economics. At this level, operating margins reflect businesses that are scaling with discipline without dramatic cost pressure. The portfolio's cash conversion is solid — a sign that operating profits are translating into real liquidity at the fund level. Together, these margins describe a portfolio where business quality varies — and where macro or sector headwinds could disproportionately impact the weaker-margin holdings.

Growth & Forward Outlook

Projected 12-month EPS growth of 45.1% adds a powerful forward signal — analyst consensus expects earnings to accelerate materially, which, if delivered, could make current multiples look increasingly modest. Zooming out from the valuation discussion, TTM revenue growth of 61.21% pointing to sustained and broad-based revenue growth within the basket, while the estimated 12-month price change of 20.88%, where target prices point to mid-range appreciation potential from current levels. Anchoring to reported revenues provides discipline; analyst price targets add context about how the market currently values that operating reality. The path to realizing analyst-implied returns runs through revenue execution, margin stability, and a macro environment that doesn't undermine either. The estimated 12-month price change is a weighted composite of analyst price target estimates adjusted by each holding's ETF weight, sourced from publicly available data, and should not be interpreted as a reliable prediction of future performance.

Conclusion

Strong Buy

The quantitative profile, taken as a whole, is above average on virtually every dimension that matters for long-term return generation.

These findings are based solely on the metrics presented and do not constitute an investment recommendation. Always perform your own due diligence before committing capital.